 Iveric Bio Inc NASDAQ: ISEE has shared the new post-hoc analyses of GATHER1 and the progress of GATHER2 clinical trials evaluating Zimura avacincaptad pegol for geographic atrophy G.A. secondary to age-related macular degeneration AMD. 